Floatz logo

DPA-714

Epilepsy, Post-Traumatic

University of California, DavisSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Epilepsy, Post-Traumatic cohort.

Asset / SponsorPhaseRating
Keppra
Cambridge University Hospitals NHS Foundation Trust
Phase 3BB

Same molecule, other indications

DPA-714 is also rated in:

subjective cognitive declineDormant
CC
Indicative ·
47 / 100
View asset →
Parkinson diseaseDormant
CC
Indicative ·
46 / 100
View asset →
cognitive disorderDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →